Polygenic score modifies risk for Alzheimer’s disease in APOE ε4 homozygotes at phenotypic extremes.

Diversity in cognition among apolipoprotein E (APOE) ε4 homozygotes can range from early-onset Alzheimer’s disease (AD) to a lifetime with no symptoms.